What is MRES stock price today?

MRES (Institute of Biomedical Research Corp) stock is trading at $0.00 as of the latest market data. Stock prices update in real-time during market hours (9:30 AM - 4:00 PM ET).

Is MRES stock going up or down today?

MRES stock price movements are influenced by market conditions, news, earnings reports, and investor sentiment. Check our live dashboard for real-time price changes and technical indicators.

Should I buy MRES stock now?

The decision to buy MRES depends on your investment strategy, risk tolerance, and financial goals. Our AI analysis evaluates fundamentals, valuation metrics, growth prospects, and market conditions to help inform your decision.

Is MRES a buy, hold, or sell right now?

Our AI-powered analysis provides buy/hold/sell recommendations for MRES based on multiple factors including valuation, growth metrics, technical indicators, and analyst consensus. Visit our dashboard for the latest recommendation.

Is MRES stock overvalued or undervalued?

Use our DCF valuation calculator to determine if MRES is overvalued or undervalued based on fundamental analysis and future cash flow projections.

What is MRES's P/E ratio?

P/E ratio data for MRES will be available after the company reports earnings. Visit our dashboard for the latest financial metrics.

What is MRES's market cap?

MRES (Institute of Biomedical Research Corp) has a market capitalization of $0.01 billion, making it a small-cap stock.

What is MRES's price to book ratio?

MRES trades at a price-to-book (P/B) ratio of 0.69, which compares the stock price to the company's book value per share. A P/B below 1.0 may indicate undervaluation, while above 3.0 may suggest premium pricing.

Does MRES pay dividends?

MRES does not currently pay dividends. Many growth companies reinvest profits into the business rather than paying dividends.

What is MRES's dividend yield?

MRES does not currently pay dividends or dividend data is not available. Check our dashboard for the latest information.

Is MRES stock a good long-term investment?

MRES's long-term investment potential depends on sustainable competitive advantages, revenue growth, profitability, management quality, and industry dynamics. Our AI analysis evaluates these factors to assess long-term prospects.

What is MRES's revenue growth rate?

Revenue growth data for MRES is available on our dashboard with detailed financial statement analysis.

Profitability metrics for MRES are available on our dashboard with complete income statement analysis.

What are the risks of investing in MRES?

Key risks for MRES include market volatility, competitive pressures, regulatory changes, economic conditions, execution risks, and company-specific factors. Our AI analysis identifies material risks and their potential impact on valuation.

How does MRES compare to its competitors?

Compare MRES to industry peers on our dashboard using metrics like P/E ratio, revenue growth, profit margins, market share, and valuation multiples. Competitive analysis helps contextualize MRES's performance and positioning.

What is MRES's stock price target for 2026?

Our AI model provides price targets for MRES based on fundamental analysis: Bull case $0.01 (+30%), Base case $0.00 (+15%), Bear case $0.00 (-10%). Visit our prediction page for detailed forecasts.

What do analysts say about MRES?

Wall Street analysts provide ratings (buy/hold/sell) and price targets for MRES. Our dashboard aggregates analyst consensus, target prices, and recent upgrades/downgrades to help you understand professional sentiment.

When is MRES's next earnings report?

MRES reports earnings quarterly. Check our dashboard for the upcoming earnings date, analyst estimates for revenue and EPS, and historical earnings performance. Earnings reports often drive significant stock price movements.

MRES - Institute of Biomedical Research Corp

NYSE * Healthcare * Biotechnology

$0.00

+$0.00 (+11.43%)

About Institute of Biomedical Research Corp

Institute of Biomedical Research Corp. provides biomedical research and analytical services in Montenegro and internationally. Its services include regulatory control of industrial activities and products; scientific surveillance of the living environment; research and development of biomedical products and technologies; regulatory evaluation and certification of biomedical products; fundamental scientific research; and development of new diagnostic methods and experimental medical treatments. The company also researchers and develops new biomedical and food products; provides programs for graduate research studies in biomedical and environmental fields; offers two channel analog NMS, digital muscle stimulator, digital TENS, interferential, elite combination, portable four channel digital, portable ultra sound, and other healthcare devices; and provides photon red light for beauty, electric pain relief products, microcurrent electrical nerve stimulators, and high volt pulsed stimulators. In addition, it develops and commercializes microbicidal agents; disinfectant products; bandages for large burns, hard surface disinfection, microbicidal treatment of fabrics and textile products, insecticides against bed bugs and other textile goods, microbicidal towels, and mouthwash products; Purilair, an appliance that sterilizes compressed air circulating within medical instruments; colloidal silver and electro medical devices; and BioStim INF that is used for edema reduction, pain relief, and total treatment. Further, the company provides quality control, regulatory, healthcare, environmental services, environmental analysis, building decontamination, and environmental protection and management services; and regulatory certifications of new biomedical products. Institute of Biomedical Research Corp. was founded in 2010 and is based in Podgorica, Montenegro with a representative office in Montreal, Canada.

MRES Key Statistics

Market Cap

$9.47M

P/B Ratio

0.69

EPS

$-1.59

How MRES Compares to Peers

MRES is the smallest among peers, which may offer higher growth potential

P/E Rank

N/A

of 5

Margin Rank

N/A

of 5

Growth Rank

N/A

of 5

Size Rank

of 6

Company	Market Cap	P/E	Growth	Margin	Compare
MRES(This stock)	$9.47M	N/A	0%	0.0%	-
AMGNAmgen Inc	$178.24B	25.6	0%	0.2%	vs AMGN
GILDGilead Sciences	$154.03B	19.2	0%	0.3%	vs GILD
VRTXVertex Pharmaceuticals	$113.35B	31.2	0%	0.3%	vs VRTX
REGNRegeneron Pharmaceuticals	$77.77B	17.6	0%	0.3%	vs REGN
BIIBBiogen Inc	$24.26B	15.1	0%	0.2%	vs BIIB

Institute of Biomedical Research Corp Company Information

Headquarters: Ljubljanska bb, Podgorica, Montenegro, 81000, undefined
Website: mrescorp.com
Sector: Healthcare
Industry: Biotechnology

About Institute of Biomedical Research Corp

MRES Key Statistics

How MRES Compares to Peers

Institute of Biomedical Research Corp Company Information

Upcoming Events for MRES